Нейропротекторное действие агонистов дофаминовых рецепторовна примере прамипексола при лечении больных болезнью Паркинсона

Т Н Слободин · Патологiя · 2010

On the basis of long-term supervision of 66 Parkinson’s disease patients and studying of motor fluctuations and postural instability development depending on starting PD treatment (dopamine agonist pramipexole or levodopa medication nakom or madopar), considerable advantages of initial application of mirapex, that confirms its neuroprotective effect, are revealed.

Cited by 0 works.

Authors